Table 2. On-study and change from baseline plasma lipoprotein subfraction concentrations (95% confidence interval) by treatment assignment.
Adjustment | Placebo | Simvastatin & Niacin | Antioxidant vitamins | Simvastatin, Niacin & Antioxidant vitamins | Anova significance for group differences |
LDL-peak | |||||
On study | 25.82 | 26.40 | 25.48 | 26.04 | |
(25.57, 26.08) | (26.15, 26.65) | (25.25, 25.71) | (25.81, 26.27) | ||
P = 0.002 | P = 0.06 | P = 0.21 | P = 7.2×10−6 | ||
Change | 0.29 | 0.66 | −0.03 | 0.36 | |
(0.05, 0.53) | (0.42, 0.90) | (−0.25, 0.19) | (0.14, 0.58) | ||
P = 0.04 | P = 0.05 | P = 0.69 | P = 0.0008 | ||
LDL-I | |||||
On study | 0.48 | 0.40 | 0.40 | 0.35 | |
(0.41, 0.54) | (0.34, 0.46) | (0.34, 0.46) | (0.29, 0.41) | ||
P = 0.09 | P = 0.08 | P = 0.005 | P = 0.04 | ||
Change | 0.03 | −0.10 | 0.04 | −0.09 | |
(−0.05, 0.12) | (−0.18, −0.02) | (−0.04, 0.11) | (−0.17, −0.01) | ||
P = 0.03 | P = 0.98 | P = 0.03 | P = 0.02 | ||
LDL-IIa | |||||
On study | 0.52 | 0.45 | 0.41 | 0.34 | |
(0.44, 0.60) | (0.37, 0.53) | (0.34, 0.49) | (0.27, 0.42) | ||
P = 0.19 | P = 0.05 | P = 0.001 | P = 0.01 | ||
Change | 0.06 | −0.09 | 0.05 | −0.13 | |
(−0.04, 0.15) | (−0.19, 0.00) | (−0.04, 0.14) | (−0.21, −0.04) | ||
P = 0.03 | P = 0.89 | P = 0.008 | P = 0.009 | ||
LDL-IIb | |||||
On study | 0.78 | 0.52 | 0.69 | 0.51 | |
(0.67, 0.88) | (0.41, 0.62) | (0.59, 0.79) | (0.41, 0.61) | ||
P = 0.0009 | P = 0.25 | P = 0.0004 | P = 0.0005 | ||
Change | 0.05 | −0.22 | 0.05 | −0.20 | |
(−0.07, 0.16) | (−0.33, −0.11) | (−0.05, 0.15) | (−0.30, −0.10) | ||
P = 0.001 | P = 0.98 | P = 0.002 | P = 0.0001 | ||
LDL-IIIa | |||||
On study | 0.52 | 0.28 | 0.72 | 0.38 | |
(0.42, 0.62) | (0.19, 0.38) | (0.62, 0.81) | (0.29, 0.47) | ||
P = 0.001 | P = 0.006 | P = 0.04 | P = 1.2×10−8 | ||
Change | −0.05 | −0.29 | 0.09 | −0.21 | |
(−0.16, 0.05) | (−0.39, −0.19) | (−0.01, 0.19) | (−0.30, −0.11) | ||
P = 0.002 | P = 0.06 | P = 0.04 | P = 2.0×10−5 | ||
LDL-IIIb | |||||
On study | 0.16 | 0.08 | 0.19 | 0.10 | |
(0.12, 0.19) | (0.05, 0.12) | (0.15, 0.22) | (0.06, 0.13) | ||
P = 0.006 | P = 0.23 | P = 0.02 | P = 0.0001 | ||
Change | −0.03 | −0.05 | 0.03 | −0.05 | |
(−0.07, 0.01) | (−0.09, −0.01) | (0.00, 0.07) | (−0.09, −0.02) | ||
P = 0.44 | P = 0.03 | P = 0.34 | P = 0.006 | ||
LDL-IVa | |||||
On study | 0.13 | 0.10 | 0.13 | 0.11 | |
(0.11, 0.14) | (0.08, 0.11) | (0.12, 0.15) | (0.09, 0.12) | ||
P = 0.01 | P = 0.78 | P = 0.05 | P = 0.007 | ||
Change | 0.01 | −0.03 | 0.02 | −0.01 | |
(−0.02, 0.03) | (−0.05, 0.00) | (0.00, 0.04) | (−0.03, 0.01) | ||
P = 0.05 | P = 0.42 | P = 0.31 | P = 0.03 | ||
LDL-IVb | |||||
On study | 0.12 | 0.10 | 0.12 | 0.11 | |
(0.11, 0.13) | (0.08, 0.11) | (0.11, 0.13) | (0.10, 0.12) | ||
P = 0.007 | P = 0.99 | P = 0.34 | P = 0.02 | ||
Change | 0.01 | −0.01 | 0.02 | 0.00 | |
(0.00, 0.03) | (−0.03, 0.00) | (0.00, 0.03) | (−0.02, 0.02) | ||
P = 0.02 | P = 0.80 | P = 0.29 | P = 0.05 | ||
LDL-C | |||||
On study | 2.99 | 1.92 | 2.95 | 2.04 | |
(2.80, 3.18) | (1.73, 2.11) | (2.78, 3.13) | (1.87, 2.21) | ||
P = 3.3×10−15 | P = 0.77 | P = 3.9×10−13 | P<10−15 | ||
Change | −0.29 | −1.46 | −0.10 | −1.17 | |
(−0.49, −0.10) | (−1.65, −1.27) | (−0.29, 0.08) | (−1.34, −0.99) | ||
P<10−15 | P = 0.17 | P = 1.6×10−9 | P<10−15 | ||
HDL-C | |||||
On study | 0.89 | 1.03 | 0.85 | 0.93 | |
(0.84, 0.94) | (0.98, 1.08) | (0.81, 0.90) | (0.88, 0.98) | ||
P = 0.0003 | P = 0.35 | P = 0.28 | P = 0.0001 | ||
Change | 0.07 | 0.22 | 0.03 | 0.15 | |
(0.03, 0.11) | (0.18, 0.26) | (−0.01, 0.06) | (0.11, 0.18) | ||
P = 2.9×10−7 | P = 0.13 | P = 0.005 | P = 4.9×10−10 | ||
Triglycerides | |||||
On study | 2.13 | 1.40 | 2.73 | 1.85 | |
(1.67, 2.59) | (0.95, 1.85) | (2.30, 3.15) | (1.43, 2.26) | ||
P = 0.03 | P = 0.06 | P = 0.37 | P = 0.0005 | ||
Change | −0.09 | −0.87 | 0.34 | −0.82 | |
(−0.48, 0.30) | (−1.25, −0.49) | (−0.01, 0.70) | (−1.17, −0.47) | ||
P = 0.006 | P = 0.11 | P = 0.007 | P = 4.9×10−6 |